UTI Healthcare Fund
UTI Mutual Fund · INF789F01TO9 · Direct
NAV ₹385.75 as of 07 Aug 2026
Latest available portfolio · Retrieved: 8-Aug-2026 11:17 PM IST · Disclosure date not provided
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | +0.2% | +4.7% | +11.7% | +23.3% | +18.6% | +24.1% | +16.1% | 39/236 | — |
Top Holdings latest available
| # | Company | Value (₹ Cr) | % of AUM |
|---|---|---|---|
| 1 | Sun Pharmaceuticals Industries Ltd | 111.8 | 8.54% |
| 2 | Ajanta Pharma Ltd | 66.4 | 5.08% |
| 3 | Divi's Laboratories Ltd | 62.0 | 4.74% |
| 4 | Gland Pharma Ltd | 53.7 | 4.11% |
| 5 | Caplin Point Laboratories Ltd | 52.5 | 4.02% |
| 6 | Lupin Ltd | 49.3 | 3.77% |
| 7 | Apollo Hospitals Enterprise Ltd | 46.0 | 3.52% |
| 8 | Alkem Laboratories Ltd | 41.1 | 3.14% |
| 9 | Dr Reddy's Laboratories Ltd | 39.4 | 3.01% |
| 10 | Max Healthcare Institute Ltd Ordinary Shares | 39.0 | 2.98% |
| 11 | Fortis Healthcare Ltd | 38.3 | 2.93% |
| 12 | Ipca Laboratories Ltd | 35.7 | 2.73% |
| 13 | Global Health Ltd | 34.2 | 2.61% |
| 14 | Anthem Biosciences Ltd | 32.6 | 2.49% |
| 15 | Cohance Lifesciences Ltd | 31.9 | 2.44% |
| 16 | Procter & Gamble Health Ltd | 31.6 | 2.42% |
| 17 | Viyash Scientific Ltd | 30.4 | 2.32% |
| 18 | Glenmark Pharmaceuticals Ltd | 28.6 | 2.18% |
| 19 | Sai Life Sciences Ltd | 28.3 | 2.17% |
| 20 | Marksans Pharma Ltd | 27.3 | 2.09% |